Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

21.76
Delayed Data
As of Aug 03
 +0.02 / +0.09%
Today’s Change
9.38
Today|||52-Week Range
25.56
+80.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues11.0M9.3M21.2M8.6M
 
 
 
 
 
Depreciation And Amortization2.0M2.3M2.2M2.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses35.3M36.3M35.1M28.3M
 
 
 
 
 
Research And Development24.1M27.5M26.2M22.7M
 
 
 
 
 
Total Operating Expenses37.3M38.6M37.3M30.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.4M-29.3M-16.1M-22.1M
 
 
 
 
 
Other Expenses62.0K62.0K62.0K88.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.2M-29.1M-16.0M-21.9M
 
 
 
 
 
Net Income-26.2M-29.1M-16.0M-21.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.5M51.5M52.3M54.5M
 
 
 
 
 
Shares To Calculate EPS Diluted51.5M51.5M52.3M54.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.56-$0.31-$0.40
 
 
 
 
 
EPS Diluted-$0.51-$0.56-$0.31-$0.40